Renal Resistive Index as a Predictor of Renal Involvement in Rheumatoid Arthritis

Launched by ASSIUT UNIVERSITY · Jan 25, 2024

Keywords

ClinConnect Summary

This clinical trial is designed to study how a specific measurement called the renal resistive index can help predict kidney problems in patients with rheumatoid arthritis, a condition that causes joint inflammation and pain. Researchers want to find out if this index can be an early warning sign for kidney issues in these patients. The trial is not yet recruiting participants, but it aims to include individuals aged 65 to 74 who have rheumatoid arthritis, whether or not they currently have kidney problems.

To be eligible for the study, participants must have rheumatoid arthritis and some may be taking medications for their condition. However, individuals with other serious conditions, such as diabetes or liver disease, will not be able to participate. If you join the trial, you can expect to undergo assessments related to your kidney health, but details about the exact procedures will be provided by the research team. This trial is important because it could lead to better ways to monitor and manage kidney health in patients with rheumatoid arthritis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients of rheumatoid arthritis è renal affection
• • Patients of rheumatoid arthritis without renal affection
• • Patients of rheumatoid arthritis on drugs (NSAIDs, DMARDS, methotrexate..).
• Exclusion Criteria:
• • Diabetic and hypertensive patients, patients with hepatitis B, C viruses or liver cell failure, patients with acute kidney injury, patients with another autoimmune disease as (SLE, sjogren disease, multiple sclerosis, patients with malignancy, patients on another drugs otherwise rheumatoid arthritis drugs).